Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that sandalwood and rose absolute oils significantly accelerated hair regrowth in a shaved mouse model, suggesting their potential for use as hair growth stimulators.

This study found that Scalp med®, a solution including minoxidil, significantly improved hair count and thickness in men with androgenetic alopecia after 24 weeks of treatment.

This study found that a 3% mixture of peppermint and rosemary oil in jojoba oil promoted hair regrowth in C57BL/6 mice similarly to minoxidil and showed notable antibacterial effects.

This study found that while the new cytopurine/pentadecanoic glyceride topical solution significantly improved total hair and daily shed hair counts in AGA patients, it did not show significant differences compared to placebo in other measures.

This study found an imbalance in autonomic nervous system activity in patients with androgenetic alopecia, with increased sympathetic activity and decreased parasympathetic activity compared to a control group.

This study observed that in men with androgenetic alopecia, hair density improved and the mean number of telogen hair bulbs decreased after weekly treatments over a year.

This study found that PLX, a mixture of tomato extract and chitooligosaccharide, may reduce prostate weight in testosterone-induced BPH in rats, suggesting it could act as a 5α-reductase inhibitor.

This study found that Saengbal-eum(Shengfa-yin) promoted hair regrowth in a mouse model similarly to 3% Minoxidil, with its effects potentially linked to EGF activity in hair roots.

This study found that increased expression of type 2 TGF-β and type II receptor was observed in the bald vertex area of hair follicles from androgenetic alopecia patients, suggesting a role in catagen induction.

Finasteride may help treat hair loss in postmenopausal women.

This study found that Procare and Proscar® finasteride tablets were bioequivalent according to Korea Food and Drug Administration guidelines in healthy male subjects.

This study observed that finasteride treatment was more effective in treating prostatitis-related hemospermia compared to non-prostatitis cases, particularly after excluding sonographically abnormal cases.

This case report observed that a 23-year-old man developed painful unilateral gynecomastia after two months of low-dose finasteride treatment for male androgenetic alopecia, which resolved after discontinuation.

In this study, a 34-year-old male developed allergic contact dermatitis on the scalp after using minoxidil solution for androgenic alopecia, with the reaction potentially linked to the propylene glycol in the product.

Combining α-blockers and Finasteride is useful for treating small prostate enlargement.

The project developed and tested a method using plasma rich platelets to treat hair loss.

This study found that combining platelet-rich plasma injections with minoxidil in treating androgenetic alopecia increased the number of hair follicles, anagen phase hairs, and decreased telogen phase hairs compared to minoxidil alone.

This open-label study suggests that combining valproate, lamotrigine, and a benzodiazepine can significantly reduce the frequency of epileptic drop attacks in patients with generalized or multifocal epilepsies.

This review examines the long-standing use of "Dictamnus" in traditional medicine, highlighting the promising potential of D. albus and D. hispanicus as herbal drug candidates, but presents no new experimental findings.

A single long white eyelash is a rare but benign condition.

Stem cell therapies show promise for healing skin wounds but need more testing.

In this narrative review, researchers evaluated existing literature on the treatment of frontal fibrosing alopecia, finding that while no curative treatment exists, clinical improvements can be achieved through personalized and combined therapy approaches.

This review of existing literature reports that photobiomodulation shows high effectiveness and safety in treating dermatological conditions like acne, psoriasis, and alopecia, though standardized clinical trials are needed to further validate its therapeutic benefits.

In this retrospective study, researchers found that baricitinib was effective for treating moderate to severe alopecia areata, with response rates in 24 patients comparable to existing real-world data, and no new safety concerns were identified.

In this study, low-dose oral minoxidil was found to have a favorable safety profile for treating alopecia, with mostly mild side effects, in both general and hypertensive populations.

This study found that while iron depletion through phlebotomies is safe for women with functional ovarian hyperandrogenism, it does not improve their cardio-metabolic profile and may reduce non-enzymatic antioxidant capacity.

This study found that home use of low-level light therapy reduced inflammation and symptoms like itching and burning in women with frontal fibrosing alopecia over six months.